Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02163356
Title Fenretinide Lym-X-Sorb + Ketoconazole + Vincristine for Recurrent or Resistant Neuroblastoma
Acronym SPOC2013-001
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors South Plains Oncology Consortium
Indications
Therapies
Age Groups: adult | child
Covered Countries USA


No variant requirements are available.